- Generic drug maker Teligent files for bankruptcy protection, explores sale of the companybizjournals.com
- Teligent regains compliance with two Nasdaq listing requirements, has one more to gobizjournals.com
- MTeligent stock up 12% after FDA approves generic steroid creammarketwatch.com
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.